Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's easy. 100% of companies that received same letter also received CRL.
Many drugs were approved eventually but that required corrective actions and new NDA.
How your irrefutable logic explains FDA sending same exact letter to other companies in the past and shortly after issuing CRL for either safety or efficacy reasons?
This FDA letter is a material event and has to be made public by SEC rules.
Yes, jesselivermore. What happened to him? He used to be very active on this board.
What happened to that plastic surgeon from Orlando? I don't see him posting anymore.
Good for you HD! You totally deserve it and I'm glad you followed your plan (sell after RI results) and didn't let JT take you on a second trip to nowhere.
In AZN case court was involved but AMRN & AZN reached some sort of agreement prior to court's ruling. I don't think details were ever made public but AZN never launched Crapanova as a result.
It's amazing how Amarin was able to defend its patents against Teva, AZN, and many other smaller generics for years, but lost it all shortly after hitting RI jackpot. Something's fishy here.
Unfortunately the time to sell was 2 years ago when RI results were just published. Too late now. I doubt JT will get any meaningful premium on top of today's share price.
That plastic surgeon was right about Vascepa but so wrong about the company. Sam made out like a bandit when he sold his shares shortly after FDA approval and disappeared into the sunset.
They built Senhance in Italy.
That's typical for any immature investor. Market will teach him a lesson quickly.
OmegaVia EPA500 is available on Amazon again.
BB,
Any updates on ITC case?
Actually $15.
$50 was a potential BO price.
Invest,
You'll be fine. This is a very safe procedure. Less than 1% complications. My 73y.o. mom just had it yesterday.
Good luck!
Too many investors are sitting on huge gains is not healthy for the stock.
ITC ruling is still a wild card. Unfavorable decision and the stock will dive under $10 in no time.
It's irresponsible to do not take some profits off the table especially for those who's been suffering here for many years.
I saw relatively large blocks on the ask driving the price down in the afternoon. Some hedges are exiting taking quick profits. Too many folks are sitting on huge profits waiting for a reason to take their money off the table. Quick sell off perhaps even down to $10 is possible.
No stock can go up indefinitely. IMO Amarin is due to a small pullback which is very healthy.
You are correct. If you had losses in previous years you can use them all in a single year to offset your capital gains.
I'm seeing a lot of DS O3 commercials on TV at my gym. Those scumbags wasting no time.
Did you guys know Amarin trades on Frankfurt exchange?
That's new to me. Here is the link.
https://www.bloomberg.com/quote/EH3A:GR
Pyr,
No, your made up BS does not bother me. The patents are solid and don't expire until 2030. In fact, Amarin will get even more new patents based on RI data.
Pyr,
Give a rest to your FUD machine. We are fine. Patents are bulletproof. At least until 2030.
Ask AZN. lol
Because of that comment we lost all gains yesterday at some point. But as long as tutes continue to accumulate, we are fine.
Kev,
No doubt V will be selling itself, but Amarin still needs more reps. If we don't see new reps being hired in the next several days/weeks. That would be a strong hint IMO of a BO being in the works.
You did the right thing.
No new sales jobs posts. No hires yet according to cafepharma.
Amarin doesn't seem to be in a hurry to proceed with its expansion plan. Perhaps JT is working on other priorities. Exciting times perhaps!
$20 will happen a lot sooner than "this time next year".
No job offers yet. Maybe a clue on the company considering other alternatives:)
http://www.cafepharma.com/boards/threads/offers.628081/page-2
IMO if the company was ever going to be sold, the time is now.
$50 PPS sounds about right if JT can pull it.
I think $20 ahead of AHA conference. Only a BO can bring valuation to $50 in such a short time frame.
But hey canapes pharma stocks trade at $16bil valuation no problem. So who knows.
I agree $2bil is a joke. Lovaza was doing $1bil on >500Tgs indication alone.
The street still gates it wrong. lol
The paradigm is shifting!
"This is exactly what is already happening. Norman Lepor, a cardiologist at Cedars-Sinai Heart Institute and professor of medicine at UCLA, called this data a “game-changer” and that the results will “impact how I treat patients starting tomorrow.”"
https://investorplace.com/2018/09/the-party-in-amarin-stock-is-just-getting-started/
It will fall. I see a buying pressure into the close. $12+ close would be nice.
Tutes are collecting shares from impatient retail longs. Plus DTs are flipping shares back and forth for penny profits.
CITI is getting on board with $50 PPS target.
https://seekingalpha.com/news/3392465?source=ansh $AMRN, $ACST
Smart Elf!
$30-$45
20mil shares traded in PM.